Viewing Study NCT06613360


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-05-24 @ 1:58 PM
Study NCT ID: NCT06613360
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-09-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Sponsor: Cullinan Therapeutics Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SLE View
None SLE (Systemic Lupus) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Systemic Lupus Erythematosus View